Gene · 701
Papers3,969
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,969
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| m6A demethylase ALKBH5 maintains stemness of intrahepatic cholangiocarcinoma by sustaining BUB1B expression and cell proliferation. | Transl Oncol | 2024 | 38242006 | PubTator, text mining | PubMed |
| PRADclass: Hybrid Gleason Grade-Informed Computational Strategy Identifies Consensus Biomarker Features Predictive of Aggressive Prostate Adenocarcinoma. | Technol Cancer Res Treat | 2024 | 38226611 | PubTator, text mining | PubMed |
| A Pan-Cancer Analysis of the Immunological and Prognostic Role of BUB1 Mitotic Checkpoint Serine/Threonine Kinase B (BUB1B) in Human Tumors. | Clin Lab | 2024 | 38213208 | PubTator, text mining | PubMed |
| Upregulation of TTK expression is associated with poor prognosis and immune infiltration in endometrial cancer patients. | Cancer Cell Int | 2024 | 38195567 | PubTator, text mining | PubMed |
| Multimerization of a disordered kinetochore protein promotes accurate chromosome segregation by localizing a core dynein module. | J Cell Biol | 2024 | 38180477 | PubTator, text mining | PubMed |
| Suppression of DNMT1 combined with ATM or ATR inhibitor as a therapeutic combination of acute myeloid leukemia. | Anticancer Drugs | 2024 | 38164802 | PubTator, text mining | PubMed |
| Catalase Expression Is an Independent Prognostic Marker in Lung Adenocarcinoma. | Anticancer Res | 2024 | 38159982 | PubTator, text mining | PubMed |
| SETDB2 interacts with BUBR1 to induce accurate chromosome segregation independently of its histone methyltransferase activity. | FEBS Open Bio | 2024 | 38151757 | PubTator, text mining | PubMed |
| Small-molecule inhibition of kinesin KIF18A reveals a mitotic vulnerability enriched in chromosomally unstable cancers. | Nat Cancer | 2024 | 38151625 | PubTator, text mining | PubMed |
| Rescue of p53 functions by in vitro-transcribed mRNA impedes the growth of high-grade serous ovarian cancer. | Cancer Commun (Lond) | 2024 | 38140698 | PubTator, text mining | PubMed |
| RNA sequencing and target long-read sequencing reveal an intronic transposon insertion causing aberrant splicing. | J Hum Genet | 2024 | 38102195 | PubTator, text mining | PubMed |
| BubR1 and cyclin B1 immunoexpression in pleomorphic adenoma and polymorphous adenocarcinoma of minor salivary glands. | Pathol Res Pract | 2024 | 38043194 | PubTator, text mining | PubMed |
| Mosaic variegated aneuploidy syndrome with tetraploid, and predisposition to male infertility triggered by mutant CEP192. | HGG Adv | 2024 | 37981762 | PubTator, text mining | PubMed |
| Improving diagnostic precision in primary ovarian insufficiency using comprehensive genetic and autoantibody testing. | Hum Reprod | 2024 | 37953503 | PubTator, text mining | PubMed |
| PP2A inhibition causes synthetic lethality in BRCA2-mutated prostate cancer models via spindle assembly checkpoint reactivation. | J Clin Invest | 2024 | 37934606 | PubTator, text mining | PubMed |
| A farnesyl-dependent structural role for CENP-E in expansion of the fibrous corona. | J Cell Biol | 2024 | 37934467 | PubTator, text mining | PubMed |
| Knockdown of BUB1B Inhibits the Proliferation, Migration, and Invasion of Colorectal Cancer by Regulating the JNK/c-Jun Signaling Pathway. | Cancer Biother Radiopharm | 2024 | 37782908 | PubTator, text mining | PubMed |
| Circular mRNA: A novel therapeutic agent. | Biotechnol Notes | 2023 | 39416918 | PubTator, text mining | PubMed |
| Personalization of Therapy in High-Grade Serous Tubo-Ovarian Cancer-The Possibility or the Necessity? | J Pers Med | 2023 | 38248751 | PubTator, text mining | PubMed |
| Definition of the Neurotoxicity-Associated Metabolic Signature Triggered by Berberine and Other Respiratory Chain Inhibitors. | Antioxidants (Basel) | 2023 | 38247474 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/701/papers?page=12